Despite these observations, treatment with anti-PD-1 and anti-LAG-3 antibodies failed to enhance the survival of leukemia-bearing mice transferred with TCRTg101 (Figure 4E) and did little to reverse the dysfunctional TCRTg101 phenotype (Figures 4F–4I). Here, PDCD1 is linked to leukemia.